Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001567619-19-005674

EVP, Chief Financial Officer acquired 10,162 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LINDAHL RICHARD S · EVP, Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2019-02-26 Grant or award : show line 1 in the form +5,081 16,615 D
2019-02-26 Grant or award : show line 2 in the form +5,081 21,696 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-02-26 Grant or award : show line 3 in the form Employee Stock Option (Right to Buy) +20,321 $61.01 $1,239,784 20,321 D
Loading xslF345X03/doc1.xml…